Clinical trial
Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a…
NCT00152802 · University Health Network, Toronto, Other · Unknown status
Key facts
| NCT number | NCT00152802 |
|---|---|
| Title | Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine |
| Official title | Immunogenicity of Pneumococcal Vaccine in Liver Transplant Recipients Using a Conjugate-Polysaccharide Priming-Booster Strategy |
| Lead sponsor | University Health Network, Toronto, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Transplant |
| Intervention type | Biological |
| Interventions | The polysaccharide vaccine Pneumovax (Merck-Frosst), The conjugate vaccine used will be Prevnar (Wyeth vaccines) |
| Enrollment | 130 |
| Start date | Jan 1, 2005 |
| Completion | Jan 1, 2009 |
| First posted | Sep 9, 2005 |
| Last update posted | Feb 19, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: